Related by context. All words. (Click for frequent words.) 61 H#N# VLP vaccine 61 CBLC# 60 MAGE A3 ASCI 59 VIR# 59 OncoVEX GM CSF 59 adenovirus vector 59 Cytolin R 59 GRNVAC1 58 Phase Ib IIa 58 lentiviral vector 58 LC#m# 58 OncoVex 57 Cytolin ® 57 SEQureDx ™ 57 Phase #b/#a clinical 57 oncolytic viruses 57 Onconase 57 inactivated vaccine 56 CEVA DSP core 56 UPLYSO 56 TriGrid 56 genetically attenuated 56 trastuzumab DM1 T DM1 55 Anthim 55 phase Ib clinical 55 ToGA 55 monoclonal antibodies mAbs 55 PSMA ADC 55 fidaxomicin Phase 3 55 moxidectin 55 lenalidomide Revlimid R 55 CEQ# 55 NVA# 55 Medarex UltiMAb R 55 GeoVax HIV AIDS 55 GeoVax vaccine 55 PREVENT IV 55 Reolysin 55 ReN# 55 Multimeric 54 Corlux 54 tolevamer 54 rBChE 54 riociguat 54 phase IIb clinical 54 BrachySil 54 oral rivaroxaban 54 vivo validation 54 HyperFeed ® 54 retapamulin 54 novel VDA molecule 54 LymphoStat B TM 54 OHR/AVR# 54 randomized controlled multicenter 54 ELISPOT assay 54 Fodosine 54 LabCorp conducts clinical 54 recombinant spider silk 53 recombinant vaccine 53 zinc finger nuclease 53 adeno associated viruses 53 DepoVax TM 53 Crucell PER.C6 ® 53 OvaRex ® MAb 53 Ophena 53 bioscavenger 53 diphtheria toxin 53 EDEMA3 53 confirmatory clinical 53 Gleevec resistant 53 ganetespib 53 lentivirus 53 Lovaxin C 53 EndoTAG TM -1 53 Cloretazine ® 53 rPA anthrax vaccine 52 investigational protease inhibitor 52 enzymatically active 52 TBC# 52 monoclonals 52 Phase IIb III 52 Inovio proprietary electroporation 52 acyclovir Lauriad R 52 Inovio electroporation 52 SynCon 52 drug TGN# 52 laninamivir 52 active comparator 52 paclitaxel poliglumex 52 TOLAMBA 52 oral ridaforolimus 52 lentiviral vectors 52 TRIM5 52 anti CD3 antibody 52 Nanocort 52 multicenter Phase II 52 CRD5 52 Human cl 52 PressureWire Certus 52 Phase 1a clinical 52 lowering triglyceride levels 52 fosbretabulin 52 synthetic siRNAs 52 designated HVTN 52 ganaxolone 52 phase IIa clinical 52 canakinumab 52 lysin 52 BRAF kinase 52 Shiga toxin 52 preclinical efficacy 52 CCR5 inhibitor 52 SAR# [004] 52 HuMax CD#b 51 patented NanoStat TM 51 nanomotor 51 BNC# 51 SMaRT ™ 51 tezampanel 51 ADVANCE PD 51 phase IIa 51 ENDEAVOR III 51 BRIM3 51 aleglitazar 51 DEB# 51 introduced NEUGENE 51 proprietary BiTE R 51 EchoCRT 51 pertuzumab 51 Ebola vaccine 51 DEEP AF 51 NUVIGIL ® 51 Cloretazine R 51 DXL# 51 TELCYTA 51 pivotal bioequivalence 51 proprietary BiTE ® 51 Exherin TM 51 receptor inhibitor 51 CCR5 antagonist 51 iPSC 51 Pagoclone 51 EXPLORE Xa 51 proprietary PEGylation 51 humanized mice 51 Cerenia 51 mousepox virus 51 SEPET TM 51 DepoFoam 51 ToleroMune 51 PFO migraine 51 Mosquirix 51 Tolamba 51 Bt toxins 51 AERAS-#/Crucell Ad# 51 TRIM5a 51 LUVENIQ 51 Arimoclomol 51 lomitapide 51 maximally tolerated dose 51 GTC recombinant human 51 preclinically 51 PRIMO CABG 51 vitro dissolution 51 AVADO 51 dose escalation clinical 51 ralfinamide 50 monocyte derived stem cells 50 ORMD 50 transfection reagent 50 Allovectin 7 R 50 CXCR4 receptor 50 BioSilicon TM 50 adipiplon 50 UltiMAb TM 50 GSK# [001] 50 GLP toxicology studies 50 vesicular stomatitis virus 50 DCVax ® Brain 50 recombinant vaccines 50 TACI Ig 50 DNA methylation biomarkers Epigenomics 50 PF # [002] 50 Epanova 50 Endoscopic Ablation System 50 TRIM5 alpha 50 placebo controlled clinical 50 vemurafenib 50 Monoclonal antibodies 50 randomized Phase IIb 50 mice ferrets 50 ESPRIT therapy 50 Vectibix panitumumab 50 PrevOnco 50 NexBio 50 canagliflozin 50 assessing T DM1 50 Xelox 50 FlashLinq 50 Maximum Tolerated Dose MTD 50 ADAGIO study 50 docetaxel Taxotere ® 50 ACTCellerate 50 budesonide foam 50 NeuroFlo 50 lysostaphin 50 VNP#M 50 Adis Medunjanin awaits 50 elacytarabine 50 solanezumab 50 Phase III confirmatory 50 ORAL Sync 50 BEZ# 50 Canvaxin 50 PRIMO CABG2 50 isavuconazole 50 Pichia pastoris 50 superantigen 50 registrational Phase 50 liprotamase 50 DASISION 49 Transdel TM 49 multicentre randomized controlled 49 SRT# [003] 49 Phase IIB 49 GAMMAGARD 49 virginiamycin 49 PANVAC VF 49 ATryn ® GTC recombinant 49 nanobodies 49 BETAS 49 mousepox 49 vaginal microbicide 49 ACV1 49 phase III isavuconazole 49 Prodrug TAP technology 49 double blinded placebo 49 bacterial toxin 49 Zoraxel 49 Company TAIFUN R 49 CLARITY TIMI 49 COMFORT II 49 immunotoxins 49 Phase Ib clinical 49 SRT# [002] 49 Neuvenge 49 M. anisopliae 49 Phase IIIb clinical 49 pox vaccine 49 hpSCs 49 recombinant antibodies 49 YONDELIS 49 molecular chaperone regulator 49 OvaRex MAb 49 CURE AF 49 demonstrated antitumor activity 49 Syncria 49 recurrent metastatic 49 nonpathogenic 49 Phase Ib clinical trials 49 OMP #M# 49 Medidata Designer 49 landmark ATHENA 49 Trastuzumab DM1 49 davunetide intranasal AL 49 Intervention Effectiveness 49 genetically engineered mouse 49 ataluren 49 alvespimycin 49 proprietary VLP 49 inecalcitol 49 Infinium assay 49 biotechnologically 49 EmbraceAC 49 ZFP transcription factors 49 Phase 1b clinical 49 TGN# 49 optical biosensors 49 ANAVEX #-# [001] 49 generation NEUGENE antisense 49 Phase 2a trial 49 Econiche 49 Smallpox vaccines 49 NexACT 49 Heplisav 49 AAV vectors 49 multicenter randomized controlled 49 RE MODEL 48 refractory prostate cancer 48 transgenic rats 48 trastuzumab emtansine T DM1 48 Tocosol Paclitaxel 48 Provacel 48 XP #L 48 REOLYSIN ® 48 MiniFiler kit 48 Mylotarg 48 short interfering RNA 48 midstage studies 48 phase IIb study 48 Dendreon Provenge 48 FLU v 48 WX UK1 48 Cinquil 48 relapsing remitting MS RRMS 48 Transfluor 48 reactogenicity 48 ONTARGET 48 mapatumumab 48 MIST II 48 Aidsvax 48 proprietary BiTE antibody 48 Motesanib 48 candidate CRLX# 48 AE# vaccine 48 ACCEDE 48 subcutaneous PRO 48 TOCOSOL Paclitaxel 48 bacterium Listeria 48 RONDEL ™ 48 siderophore 48 prospective randomized placebo 48 VITAL Trial 48 midstage trials 48 cyclophilin inhibitors 48 metastatic hormone refractory 48 embryonic stem cells ESCs 48 randomized Phase III 48 Bexion 48 randomized controlled Phase 48 phase 2a 48 MitoQ 48 recombinant insulin 48 Smallpox vaccine 48 Phase Ib II 48 transgenic animal 48 rALLy clinical trial 48 avian H#N# 48 Val HeFT 48 tanespimycin 48 vosaroxin 48 Anidulafungin 48 Phase IIa clinical 48 VersaFilm 48 Teflaro 48 phase IIb III 48 bardoxolone 48 Omapro 48 Phase #b/#a trial 48 Anturol TM 48 antibiotic ampicillin 48 lipidoid 48 COR Diabetes 48 Bacillus subtilis 48 Crucell PER.C6 R 48 Neo Bladder Augment 48 Novo TTF 48 hypoxia activated prodrug 48 Phase III VISTA 48 influenza VLP vaccines 48 Long Lesion 48 Vaxfectin TM 48 Phase Ia 48 acai pill 48 Onalta ™ 48 variola 48 GSK# [002] 48 Batten afflicted 48 Ushercell 48 Iomega floppy USB 48 polyclonal antibodies 48 evaluating satraplatin plus 48 treatment naive genotype 48 SUTENT ® 48 ancrod 47 MyVax 47 Lucanix R 47 prospective randomized multicenter 47 LabCorp conducts clinical trials 47 GLPG# 47 biodegradable nanoparticles 47 trastuzumab Herceptin ® 47 product ProBiora3 47 nano encapsulation technology 47 BRAF inhibitor 47 olfactory receptor 47 Allovectin 7 ® 47 Company proprietary INACTINE 47 olaparib 47 tesofensine 47 Alfimeprase 47 Rheos System 47 Propionibacterium 47 CCR2 antagonists 47 NP2 Enkephalin 47 vitro experiments 47 proprietary albumin fusion 47 home eldercare evaluation 47 TBC M4 47 Archexin 47 www.ingenuity.com 47 Hyphanox 47 RSD# oral 47 RhuDex 47 tribulations Groenveld 47 Asentar 47 Pimavanserin 47 phase Ib 47 Burkholderia 47 Orazol 47 Phase #b/#a 47 neratinib 47 CB2 selective receptor agonist 47 GeneChip R 47 CRLX# 47 oral deforolimus 47 TASKi3 47 O# H7 strain 47 multicenter Phase III 47 Vacc 4x 47 enrofloxacin 47 includes TOLAMBA TM 47 masitinib 47 HepaGam B 47 Twinrix 47 thorough QT 47 antibiotic Trovan 47 DiabeCell 47 MyoCell ® 47 performance S6 sedan 47 investigational 47 recurrent glioma 47 cannabinor 47 ONCONASE R 47 Viprovex R 47 Saxagliptin 47 Phase IIa proof 47 REMUNE R 47 drug conjugates ADCs 47 tramiprosate Alzhemed TM 47 NO# [002] 47 Pasteuria 47 bioabsorbable stent 47 baculovirus expression system 47 xMAP 47 human antithrombin 47 viral vectors 47 DPOLT 47 Amoxicillin PULSYS Phase III 47 multicenter randomized clinical 47 hepatitis B vaccine Heplisav 47 Organic Rankine Cycle ORC 47 TheraCIM h R3 47 proprietary Mimetic Ligand 46 Variant Creutzfeldt Jakob 46 TMC# C# 46 Trial Initiative LSTI 46 #mg ATC 46 cyclosporin 46 multidose 46 prove exculpatory inculpatory 46 pharmacokinetic PK study 46 APEX PD 46 Multikine ® 46 confirmatory Phase 46 immunological diseases 46 CALGB # [002] 46 randomized controlled clinical 46 induced pluripotent cells 46 RE LY ® 46 trastuzumab DM1 46 Marburg Musoke 46 Phase IIb clinical trials 46 double blinded randomized 46 galiximab 46 topical testosterone 46 TAXUS ATLAS 46 Affibody ® molecules 46 SUCCEED trial 46 modified REGENESIS Phase IIb 46 phase IIb 46 RainStorm 46 EBx 46 randomized multicenter Phase III 46 Fentanyl TAIFUN R 46 Phase III placebo controlled 46 bacterium Bacillus thuringiensis 46 cellulose sulphate 46 PSN# [002] 46 VADT 46 Raptiva ® 46 OvaRex 46 tremelimumab 46 Nimotuzumab 46 Cannabinor 46 human parthenogenetic stem 46 NSABP C 46 spectroscopic technique 46 Diamyd ® 46 Phase 1b trial 46 incyclinide 46 transgenesis 46 Valtropin 46 Xyotax 46 epothilone KOS 46 iSONEP 46 chitinase 46 National Emphysema Treatment 46 Bacillus thuringiensis bacterium 46 identifier NCT# 46 Medidur TM FA 46 MAPCs 46 DXL TM antibodies 46 telomerase gene 46 AIDSVAX vaccine 46 enzymatic pathway 46 microplate instrumentation 46 PERSEUS 46 cellulose sulfate 46 CATIE AD 46 anastrazole 46 albiglutide 46 RE LY 46 name Biospherics 46 multicenter randomized placebo controlled 46 Huggins Cams Time 46 regarding Aethlon Medical 46 Probuphine 46 prion gene 46 PROSTVAC TM 46 ABSORB clinical 46 Phase #/#a 46 Phase III psoriasis 46 Vindicator LWS 46 viral kinetic 46 bioequivalency 46 Telintra 46 WWW browser 46 TAXUS IV 46 phage display 46 Prednisporin TM 46 midstage clinical trials 46 Bioniche E. coli 46 Phase 1b clinical trials 46 Escherichia coli E.coli 46 Viveta 46 methodologically rigorous 46 CytoFabTM 46 blinded randomized 46 immune suppressing 46 ALSYMPCA 46 bacterial fermentation 46 Independently Dyax 46 ENESTnd 45 embryo clones 45 blinded randomized placebo controlled 45 Phase IIB clinical 45 Bt toxin 45 DiabeCell R 45 confirmatory Phase 3 45 MIRCERA 45 valopicitabine 45 recurrent malignant glioma 45 bacteriophages 45 rALLy trial 45 ZFN technology 45 HGS# 45 platform Vicious Engine 45 antisense therapies 45 CARE HF 45 bacterium E. coli 45 Taxus Liberte 45 Randomised 45 biosynthetic pathways 45 Alequel 45 bacteriophage 45 spider silk proteins 45 reassortant 45 AIM HIGH 45 VeriCall Edge software 45 MMP inhibitors 45 dosing cohorts 45 myoblast therapy 45 PSC RANTES 45 irreversible electroporation IRE 45 pharmacokinetic studies 45 virulent pathogens 45 ANCHOR trial 45 GALNS 45 Phase IIa trial 45 B. cepacia 45 particles VLPs 45 Ovarian Cancer Screening 45 CHO cells 45 CDK inhibitors 45 POTELLIGENT R 45 antisera 45 MyVax personalized immunotherapy 45 EGS# 45 bicifadine 45 Coronaviruses 45 Celltick LiveScreen Media 45 Diamyd r vaccine 45 novel bioadhesive drug 45 Phase 2a clinical 45 ticagrelor Brilinta 45 Bioral Amphotericin B. 45 multicenter placebo controlled 45 bipolar wafer 45 patented NanoStat ™ 45 Clinical Antipsychotic Trials 45 antimicrobial peptide 45 ProLindac 45 RPL# 45 Eniluracil 45 RNAi gene silencing 45 SPIRIT FIRST 45 called Fairpole 45 hypercholesterolemic patients 45 neuroblocking technology 45 YieldGard Rootworm 45 multicenter clinical 45 Phase IIA 45 evaluating mipomersen 45 extralabel 45 TG MV 45 Phase IIb clinical 45 PEARL SC 45 Aryplase 45 Delivery System NTDDS 45 proprietary GelSite R 45 ASSERT trial 45 venous thrombosis indications 45 dose escalation phase 45 antiviral cytokines 45 Avian Influenza Vaccine 45 ruxolitinib 45 Merck RotaTeq 45 eldercare evaluation 45 clinical trials SGN 45 EURIDIS 45 prion strains 45 Phase 1a 45 dirucotide MBP# 45 ENDEAVOR IV 45 Phase 2b kidney transplant 45 Varroa destructor 45 RTS S/AS# 45 AIDSVAX flunked 45 Phase III clinical 45 ALK inhibitors 45 AquaBounty Technologies 45 dose escalation Phase 45 LUMINATE 45 opioid naive 45 tan wrappings 45 doxorubicin docetaxel 45 motesanib 45 Initiated Phase 45 IMPACT DCM clinical 45 multicenter phase 45 Geotextile tubes 45 patented BEMA 45 Cloretazine R VNP#M 44 Multicenter Automatic Defibrillator Implantation 44 rotary VAD 44 including eniluracil ADH 44 Intervention Effectiveness CATIE 44 endogenous retrovirus 44 postnatal foreskin fibroblasts 44 Thorough QT 44 multicentre randomized 44 Prostate AdenoCarcinoma Treatment 44 HCV SPRINT 44 naturally occurring bacterium 44 AVERROES 44 Phase 2a preventative 44 artificial chromosomes 44 e2 Collector 44 underlying CSRV 44 Phase Ib 44 abiraterone 44 advanced polymer conjugate 44 Pesticide Testing 44 NovaDel oral spray 44 myxoma virus 44 reprogrammed stem cells 44 randomized multicentre 44 Phase III Clinical Trials 44 SILENOR 44 ABSORB trial 44 electro optic modulator 44 Exosome Sciences 44 Baytril 44 manufactures revolutionary 5kW 44 GTC Biotherapeutics Inc 44 IIa trial 44 TAXUS VI 44 arzoxifene 44 KellBenx 44 CHAMPION PCI 44 Robert Langer ScD 44 HCV RESPOND 2 44 Phase 2a clinical trials 44 HIVNET 44 transgenic silkworms 44 resminostat 44 pharmacokinetic characteristics 44 patented TruePrint ® 44 proprietary Customized Linker 44 AVN# Phase 44 multicenter Phase 44 Tangshan Yian 44 ONTARGET R 44 AvalonRx R 44 SPIRIT IV 44 GENASIS clinical 44 randomized blinded 44 Greensteam 44 CUSTOM III 44 Raloxifene Evaluation MORE 44 iPrEx study 44 ZapMedia applied 44 Urocidin 44 Tykerb lapatinib 44 nanometer CMOS process 44 Cogane 44 ImmuneY2 TM drug 44 NSABP B 44 insecticidal properties 44 axitinib 44 antimycin 44 cellulases 44 osteopontin OPN 44 afamelanotide 44 produces synthetic peptide 44 pathogenic fungus 44 AOD# [002] 44 CAMMS# 44 Etelos Platform 44 proprietary GelSite ® 44 eosinophilic asthma 44 cetrorelix pamoate 44 www.aethlonmedical.com 44 Advagraf 44 gibbon ape 44 Phase lll 44 blinded placebo controlled 44 LibiGel Phase III 44 XL# SAR# 44 Oglemilast 44 myopic CNV 44 temsirolimus 44 Exelixis compounds 44 intravenous cyclophosphamide 44 defensins 44 ICA # 44 prospective multicenter 44 DIABECELL ® 44 MEND CABG 44 tezampanel NGX# 44 multicenter trials 44 spore forming 44 mutating viruses 44 biochemical assays 44 Phase IIa trials 44 DIABECELL 44 Movento 44 Gabapentin GR 44 affecting orBec ® 44 number NCT# ClinicalTrials.gov 44 NSABP 44 Phase IIIb study 44 Agress TM 44 Edwards SAPIEN valve 44 bryostatin 44 hemoglobins 44 poxviruses 44 controlled multicenter 43 phase III ACCLAIM 43 European Sepsis Trial 43 Bavarian Nordic patented 43 labial herpes 43 Novartis Zometa 43 Dr. Jeffrey Probstfield 43 microbials 43 HCV protease inhibitors 43 receptor specificity 43 lasofoxifene 43 HPTN 43 ocrelizumab 43 Prostate Lung Colorectal 43 Randomized controlled 43 iMapWeather base 43 Ereska 43 GVAX 43 Company Nasdaq CXDC 43 proprietary cryoablation 43 genetically reprogrammed 43 cyclopamine 43 placebo controlled Phase 43 Prostate Cancer Prevention 43 Phase IIb trials 43 optimal dosing 43 RECORD1 43 BCM# transceiver 43 Ocean Treader 43 Pentad TM 43 roxarsone 43 somatotropin 43 Pulminiq 43 Telcyta 43 Oxitec 43 Clostridium 43 Delcath Phase III 43 Maopao store 43 VESTASYNC 43 ularitide 43 Onglyza saxagliptin 43 Phase 2b clinical trials 43 amygdalin 43 bioengineered microspheres 43 inhibit tumor 43 digital multicasting capability 43 mesenchymal stem cells MSCs 43 ragweed allergy immunotherapeutic 43 proprietary synthetic peptides 43 piggyBac 43 gepirone ER 43 genetically engineered 43 defensin 43 Ovonic fuel 43 Soitec Concentrix 43 reassorted 43 ACCORD Lipid 43 BLOOM DM 43 randomized controlled clinical trials 43 biosynthetic 43 Ditech Networks VQA 43 scrapie infected 43 dosage regimens 43 randomized multicenter trial 43 newest Food2.com 43 carcinogenicity study 43 PRESEPT study 43 Javascript extensively 43 activating EGFR mutations 43 placebo controlled multicenter 43 Unigene patented manufacturing 43 medavis RIS 43 GeoVax Phase 43 PCA3 test 43 fetal stem cells 43 Chip Synthesis 43 TQT studies 43 confirmatory Phase III 43 DAPT 43 worm Caenorhabditis elegans 43 capsids 43 hESC derived RPE cells 43 phase IIb trial 43 ASCEND HF 43 whipworm 43 Ragweed Allergy 43 Lupuzor 43 Board DSMB 43 DIABECELL R 43 rALLy 43 Neural Crest 43 randomized crossover 43 L. lactis 43 bile duct tumor 43 primordial germ cells 43 Prodarsan 43 MADIT II 43 Atu# 43 CHO cell 43 phase IIIb 43 gene therapy 43 Edge STudy 43 Suntech solar panels 43 Cangrelor 43 Pfizer maraviroc 43 antibiotic telavancin 43 REALITY Trial 43 ENDEAVOR IV clinical 43 IIa clinical 43 ENRICH trial 43 BST CarGel R 43 Aspergillus oryzae 43 Dacogen injection 43 Pfizer Selzentry 43 proprietary ultrasonic nozzle 43 AP IMPACT Credibility 43 superior biotherapeutics 42 AIR CF1 42 Boreal Genomics 42 nonrandomized 42 autoreactive 42 telcagepant 42 proprietary adenovector technology 42 recombinant 42 microfilariae 42 radioactive cesium isotopes 42 fund BioSante LibiGel 42 Cholesterol Levels SPARCL 42 proprietary Lipid Vector 42 Cry1Ac 42 Aspergillus niger 42 SCENESSE ® 42 Weather Bonk 42 Phase IIb kidney transplant 42 insecticidal protein 42 cybrids 42 treat premature ejaculation 42 XML : Comma 42 adjuvant colon cancer 42 PD2i CA 42 placebo controlled Phase III 42 subanalysis 42 Zactima 42 Atryn 42 GLP toxicology 42 Myostatin 42 indicated Googol 42 breathing scramjet engine 42 Company Targeted Antibody 42 spinosad 42 Kei Utsugi researcher 42 mipomersen 42 quantitative multiplexed gene 42 Zemplar Capsules 42 VLPs 42 founded Starbridge Systems 42 nano titanate 42 Chinese hamster ovary 42 proprietary Biochronomer ™ 42 Pivotal Clinical Trial 42 Vertex hepatitis C 42 prospective randomized controlled 42 LimeWire P2P 42 HOPE TOO 42 Roxarsone 42 lectins 42 chimeric embryos 42 intratumoural 42 dm crypt 42 intravenous dosing 42 Phase IIb REGENESIS 42 trials RCTs 42 Carraguard 42 IND CTA 42 USHE groundbreaking pocket BLU 42 Softransceiver 42 Plasma Enhanced Melter 42 generation PNP inhibitor 42 placebo controlled studies 42 Sorafenib HCC Assessment 42 Sennheiser pioneering 42 CALGB 42 nonclinical studies 42 Levacor 42 MPE TM 42 genetically engineered organism 42 utilize proton beam 42 transgenic animals 42 pox virus 42 Galvus vildagliptin 42 CU Boulder LASP 42 Meta analyzes 42 cellulase enzymes 42 KRN# 42 dose pharmacokinetic 42 Zilver PTX 42 prospective observational studies 42 genetic manipulations 42 baculovirus 42 phage display technology 42 TRAIL receptor antibody mapatumumab 42 patented TruePrint R 42 spermatogonial cells 42 toxicological studies 42 Rapamycin 42 drug Recentin 42 aneuploid 42 Vorapaxar 42 thale cress Arabidopsis thaliana 42 Albuferon Phase 42 MADIT 42 AMSC Windtec ™ 42 CardioComm patented 42 Phase IIb trial 42 Pivotal Trial 42 transgenic rice 42 neonicotinoid 42 transgenic mosquitoes 42 transgenic goats 42 AERAS 42 Salmonella bacterium